Commonwealth Serum Laboratories Act 1970

Overview

The Commonwealth Serum Laboratories Act 1970 was enacted to amend the Commonwealth Serum Laboratories Act 1961–1966, specifically in relation to the importation and sale of certain vaccines. This Act was passed by the Queen’s Most Excellent Majesty, the Senate, and the House of Representatives of the Commonwealth of Australia and received Royal Assent on 24 June 1970. The primary objective of this amendment was to address the need for the Commonwealth Serum Laboratories to import and sell vaccines as outlined in the National Health Act 1953–1970. This legislative change aimed to enhance the functionality of the Commission by expanding its scope to include the importation and sale of specific vaccines, thereby ensuring better public health outcomes through regulated vaccine distribution.

Scope and Application

The Commonwealth Serum Laboratories Act 1970 amends the earlier Commonwealth Serum Laboratories Act 1961–1966 to expand the functions of the Commonwealth Serum Laboratories Commission, particularly in relation to the importation and sale of specific vaccines within Australia. This Act applies to the Commonwealth Serum Laboratories Commission and pertains to their authorised activities concerning the importation and sale of vaccines as outlined in section nine b of the National Health Act 1953–1970. The geographic scope of this Act is national, as it operates within the jurisdiction of the Commonwealth of Australia. There are no specific exclusions, exemptions, or thresholds mentioned in the Act itself, although it is likely that any subordinate instruments or regulations associated with the importation and sale of vaccines would provide further detail on these aspects. This Act came into operation on the day it received Royal Assent, which was 24 June 1970.

Key Provisions

The Commonwealth Serum Laboratories Act 1970 amends the Commonwealth Serum Laboratories Act 1961–1966 primarily by expanding the functions of the Commission established under the earlier Act. Section 3 of the 1970 Act inserts a new function into Section 19 of the 1961–1966 Act, allowing the Commission to import into Australia and sell to the Commonwealth any vaccine specified in Section 9B of the National Health Act 1953–1970. This addition aims to enhance the capability of the Commission to manage and supply essential vaccines within the country. Additionally, the amendment modifies existing provisions to ensure clarity and proper referencing within the legal framework. The obligations imposed on the parties governed by this Act include ensuring that any vaccines imported and sold to the Commonwealth are in compliance with the National Health Act 1953–1970. The Commission, as the governing body, must exercise due diligence in selecting and procuring these vaccines, ensuring they meet all necessary health and safety standards. The amendment also revises the structure of the Commission by changing the numerical reference from "two" to "three" in a specific sub-paragraph, likely relating to the composition or structure of the Commission itself, although the exact nature of this change is not detailed in the provided text. Breaches of the provisions under this Act could potentially lead to various legal consequences. While the specific offences, penalties, or consequences are not detailed within the text provided, it is reasonable to infer that non-compliance with the importation and sale requirements of the vaccines could result in legal action against the Commission or other involved parties. Such actions might include fines, injunctions, or other civil remedies, depending on the nature and severity of the breach. Given the critical nature of vaccine supply and public health, severe breaches could also potentially lead to criminal charges under other related health and safety legislation.